
Senator John McCain was diagnosed with an aggressive glioblastoma after going to the Mayo Clinic for a routine exam.

Senator John McCain was diagnosed with an aggressive glioblastoma after going to the Mayo Clinic for a routine exam.

For years, the news has been full of stories about opioid addiction. I am just glad that painkillers that actually killed the pain were available when I needed them.

A breast cancer survivor looks at prescription drugs, and what we call them.

Ovarian cancer screening for women who do not have symptoms of the disease may do more harm than good, according to the USPSTF.

“If you locked everybody in a room for a week, I think we could come up with something that everybody would be comfortable with,” said Blase Polite, M.D., a co-author of the statement, and immediate past chair of ASCO’s government relations committee.

It's natural to feel overwhelmed with a cancer diagnosis. Grab back a little security by knowing what to expect

Being on blood thinner scares me.

Diagnosed with desmoplastic melanoma, sportscaster Holly Rowe is working with the Melanoma Research Foundation to teach about the disease.

CSC to release seminal research on the emotional, social, and financial burden on cancer patients


Patients with mantle cell lymphoma who were treated with Imbruvica had a better quality of life than those treated with another agent, according to the results of a recent study.

The doctor-patient relationship is a delicate one. It's one that needs to be comfortable between both parties. When and how do breast cancer patients know when it's time to make a change? This is an important decision that should not be taken lightly.

After a cancer diagnosis, it can feel as if your body has failed you. How do you go back to trusting it again?

Nerlynx (neratinib) was granted approval by the Food and Drug Administration (FDA) for the extended adjuvant treatment of patients with early stage, HER2-positive breast cancer who have already received postoperative Herceptin (trastuzumab).

An immunotherapy has become the first of its kind approved to treat Merkel cell carcinoma, a rare and still mysterious skin cancer.

Summer fun can be a challenge for survivors with lymphedema. While you should do what your doctor, physical therapist and you have worked out as best for your needs, I share some of my helpful habits here.

It is nice to know there are options and supportive programs for women who wish to use makeup to feel good about their appearance.

While a blanket, water and snacks are important for the chemo bag, don't forget to bring the good stuff like guts. No guts, no glory.

Patients with head and neck squamous cell carcinoma (HNSCC) saw an improvement or stabilization in quality of life when they were treated with Opdivo.

Creams containing the chemotherapy 5-fluorouracil can be fatal to animals, the FDA warns.

Diane Zipursky Quale, co-founder of the Bladder Cancer Advocacy Network, discusses the importance of patients discussing their treatment options with their physician before undergoing surgery.

MDS is a rare form of cancer with its own unique characteristics. Here is one patients perspective on the experience of having MDS.

Holocaust survivors had higher rates of lung and colorectal cancer, according to a recent study.

In treating rare advanced skin cancers, individualized therapy is improving outcomes.

A study is helping to motivate breast cancer survivors to be physically fit.

Immunotherapy and PARP inhibitor combinations may be the future of ovarian cancer treatment, says Samir N. Khleif, M.D.

While Underdog is a made-up cartoon character, "Hysterdog" is the real deal, and so is her love.

A helpful guide for the newly diagnosed.

There's lots of great new research to be excited about but there's still no cure.

Blincyto (blinatumomab) was granted full approval by the Food and Drug Administration (FDA) to treat both children and adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL), regardless of Philadelphia chromosome (Ph) status, according to the developer of the anti-CD19 immunotherapy, Amgen.